Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/29/2012 | CN102112132B Triterpenoid-based compound used as a virus inhibitor |
08/29/2012 | CN102106972B Medicament for treating empyrosis and scalding and acute skin bruise and contusion, preparation method and detection method |
08/29/2012 | CN102099026B Therapeutic compositions containing macitentan |
08/29/2012 | CN102093308B New crystal forms of Febuxostat and preparation methods thereof |
08/29/2012 | CN102085205B Medical compound preparation of eugenol aspirin ester and method for preparing same |
08/29/2012 | CN102085179B Ibuprofen injection and preparation method thereof |
08/29/2012 | CN102078475B Traditional Chinese medicine for treating spinal arachnoiditis and preparation method thereof |
08/29/2012 | CN102068471B Externally applied medicine for treating carbuncle diseases |
08/29/2012 | CN102068445B Method for preparing pulsatilla chinensis (Bunge) Regel saponin matter and application of pulsatilla chinensis (Bunge) Regel saponin matter in preparation of antischistosomal medicament |
08/29/2012 | CN102058579B Application of dehydrocostuslactone to preparing drug for inhibiting angiogenesis |
08/29/2012 | CN102030765B Ether-linked porphyrin dimer salt and preparation method thereof |
08/29/2012 | CN102028722B Extract of effective parts of total saponins in pterocephalus hookeri as well as preparation method and application thereof |
08/29/2012 | CN102028672B Microporous spongy film preparation and preparation method thereof |
08/29/2012 | CN102008470B Compound preparation and use thereof for preventing and treating noise induced hearing damage |
08/29/2012 | CN102008464B Application of levobutyl phthalide in preparation of medicament for preventing and treating cerebral infarction |
08/29/2012 | CN102008432B Sodium demethylcantharidate medicinal composition for injection and preparation method thereof |
08/29/2012 | CN102000215B Method for preparing total lignans of Indian stringbush root |
08/29/2012 | CN101959501B Stabilized single-liquid pharmaceutical composition containing docetaxel |
08/29/2012 | CN101955477B 2-cyclopropyl-4-substituted thiophenyl quinoline compounds as well as intermediate, preparation method and application thereof |
08/29/2012 | CN101940631B Method for preparing pollen itching-dispelling pain-relieving tincture |
08/29/2012 | CN101940617B Medicinal composition with anti-inflammatory and analgesic effects, preparation method and application thereof |
08/29/2012 | CN101912362B Fat emulsion pre-emulsifying concentrated solution for teniposide intravenous injection and preparation method thereof |
08/29/2012 | CN101909619B Composition comprising sesamin component and quercetin glycoside |
08/29/2012 | CN101906102B Beta-carboline alkaloid derivative, preparation method and application thereof |
08/29/2012 | CN101899045B 9-substituted-2-amino-6-guanidyl purine compounds as well as preparation method and application thereof |
08/29/2012 | CN101874798B Difunctional inhibitor of leukotriene A4 hydrolase and cyclooxygenase and application thereof |
08/29/2012 | CN101870696B N-aryl piperazine derivative having double activity of dopamine D2 and 5-HT2a |
08/29/2012 | CN101863998B Modified saccharides, conjugates thereof, and their manufacture |
08/29/2012 | CN101863925B Aryl ruthenium (11) composition and preparation method and application thereof |
08/29/2012 | CN101857642B Polysaccharide derivative and vanadium complex application thereof |
08/29/2012 | CN101822675B Application of aporphine alkaloid, oxoaporphine alkaloid and derivatives thereof in preparing antibacterial medicines |
08/29/2012 | CN101816635B Cephalosporin suspension granule and preparation method thereof |
08/29/2012 | CN101812103B 6-methy salicylic acid synthetase transformed by genetic engineering and combinatorial biosynthesis of spirocyclic acetoacetic acid lactone antiboitic |
08/29/2012 | CN101809039B Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent |
08/29/2012 | CN101791296B Orlistat tablets and preparation method thereof |
08/29/2012 | CN101790553B Alkylene oxide derivative and skin external preparation containing the same |
08/29/2012 | CN101784544B Thiadiazinone derivatives |
08/29/2012 | CN101778608B Artificial insemination device in mammal reproduction |
08/29/2012 | CN101766716B Hangover relieving composition |
08/29/2012 | CN101766715B Composite for disintoxicating and sobering |
08/29/2012 | CN101766637B Composite for disintoxicating and sobering |
08/29/2012 | CN101756991B Sustained-release pills of alfuzosin hydrochloride |
08/29/2012 | CN101732259B Chitosan micron particle as well as preparation method and application thereof |
08/29/2012 | CN101717413B Chiral ruthenium coordination compound and application of same as anti-tumour medicine |
08/29/2012 | CN101687887B Tricyclic nitrogen containing compounds as antibacterial agents |
08/29/2012 | CN101646429B Ataractic agent and functional food |
08/29/2012 | CN101633646B Salts of valsartan |
08/29/2012 | CN101613267B Dihydroxyoleic acid, preparation method and application thereof |
08/29/2012 | CN101583617B 4-(2-oxo-oxazolidin-3yl)-phenoxymethyle derivativeas as antibacterials |
08/29/2012 | CN101538247B Preparation method of alkaloid compound |
08/29/2012 | CN101538239B Antitumor antibiotic and preparation method thereof |
08/29/2012 | CN101538238B Polymorphs of atorvastatin tert.-butylester and use as intermediates for the preparation of atorvastatin |
08/29/2012 | CN101537129B Applications of dendrobium nobile lindl alkaloids in medicines prepared for treating ischemic brain damage and product thereof |
08/29/2012 | CN101516882B Selective antagonists of A2A adenosine receptors |
08/29/2012 | CN101497605B Benzimidazole derivative containing alkoxy substituted pyridine |
08/29/2012 | CN101496790B Acarbose chewable tablet |
08/29/2012 | CN101475524B Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation |
08/29/2012 | CN101472907B Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists |
08/29/2012 | CN101454305B Flavonoid dimers and methods of making and using such |
08/29/2012 | CN101443344B Trehalose compound and pharmaceutical comprising the compound |
08/29/2012 | CN101443315B Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
08/29/2012 | CN101429232B Hcv protease inhibitors |
08/29/2012 | CN101379041B Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
08/29/2012 | CN101331229B Immunostimulatory oligoribonucleotides |
08/29/2012 | CN101330907B Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent |
08/29/2012 | CN101321742B Compositions and methods of treating retinal disease |
08/29/2012 | CN101272767B Morphous solid dispersions of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide |
08/29/2012 | CN101269113B Quality control method for medicament composition for treating knubble |
08/29/2012 | CN101240271B Toll-like receptor adjustment oligonucleotide and use thereof |
08/29/2012 | CN101182562B Method for producing extracellular polysaccharide through golden fungus liquid fermentation and uses thereof |
08/29/2012 | CN101163796B Cationic lipids and methods of use |
08/29/2012 | CN101163684B Quinazoline derivative having tyrosine kinase inhibitory activity |
08/29/2012 | CN101155789B 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
08/29/2012 | CN101155786B N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
08/29/2012 | CN101146529B Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
08/29/2012 | CN101080251B Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents |
08/29/2012 | CN101040837B Itracomazole cream and the method for preparing the same |
08/29/2012 | CN101035786B Pyrrolopyridine derivatives and their use as CRTH2 antagonists |
08/29/2012 | CN101028519B Pharmaceutical composition for treating immune diseases |
08/28/2012 | WO2013130049A1 Method for enhancing efficacy and selectivity of cancer cell killing by dna damaging agents |
08/28/2012 | USRE43615 Method for controlling the yeast-to-filamentous growth transition in fungi |
08/28/2012 | USRE43612 Biodegradable poly(β-amino esters) and uses thereof |
08/28/2012 | US8252958 Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells |
08/28/2012 | US8252947 Solid state forms of a pharmaceutical |
08/28/2012 | US8252945 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient |
08/28/2012 | US8252940 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection |
08/28/2012 | US8252937 1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones |
08/28/2012 | US8252935 Piperidinyl and piperazinyl modulators of γ-secretase |
08/28/2012 | US8252933 2-oxo-1,2-dihydro-quinoline modulators of immune function |
08/28/2012 | US8252931 Thiazolo[5,4-B]pyridine glucokinase activators |
08/28/2012 | US8252929 8-carboxamido-2,6-methano-3-benzazocines |
08/28/2012 | US8252923 Peptidomimetic protease inhibitors |
08/28/2012 | US8252918 RNAi probes targeting cancer-related proteins |
08/28/2012 | US8252909 Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases |
08/28/2012 | US8252846 Strategies for delivery of active agents using micelles and particles |
08/28/2012 | US8252845 Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isoform |
08/28/2012 | US8252843 Compounds for the treatment of AIDS and other viral diseases |
08/28/2012 | US8252842 Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof |
08/28/2012 | US8252841 Methods of inhibiting bacterial virulence and compounds relating thereto |
08/28/2012 | US8252840 Methods of derivatives of probucol for the treatment of type II diabetes |